Key Takeaways Anti-inflammatory peptides target NF-kB, cytokine, and oxidative stress pathways without broad immunosuppression KPV, BPC-157, TB-500, and GHK-Cu are the most widely researched peptides for inflammation Mechanism of action varies some modulate NF-kB directly, others reduce inflammation through mitochondrial or hormonal pathways Research peptides are not approved for human anti-inflammatory use and should stay in a research-only context Chronic inflammation is a root driver of metabolic disease, autoimmune conditions, neurodegeneration, and accelerated aging
Hub genes were subsequently analyzed for enrichment, proteinprotein interactions (PPIs), and different immunological microenvironments, and potential hub gene were identified using MCC method and LASSO
To prolong plasma half-life and improve drug delivery, butyrate and sorafenib were co-encapsulated within antibody-functionalized mPEG-PLGA-PLL nanoparticles, which significantly reduced sorafenib-induced liver injury and suppressed hepatocellular carcinoma progression [121]
Post-procedure, continue IV fluids as long as feasible to help flush out anesthesia drugs
GHK-Cu as supplied is not intended for human therapeutic use
